Kavita Bhavan

Kavita Bhavan

Auto-generated profile, based on publicly available information

Kavita Bhavan

Department of Internal Medicine, Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Health Equity
Verified
Journal Article
Open access
SJSeema Jain
Seema Jain
RHRobin T. Higashi
Robin T. Higashi
CSCarolina Salmeron
Carolina Salmeron
KBKavita Bhavan
Kavita Bhavan
Introduction: Lack of childcare has been linked to missed health care appointments for adult women, especially for lower-income women. The COVID-19 pandemic created additional stressors for many low-income families that already struggled to meet childcare and health care needs. By exploring the experiences of women who were referred for childcare services at a U.S. safety-net health system, we aimed to understand the challenges women faced in managing their health and childcare needs during the COVID-19 pandemic. Methods: We conducted semistructured interviews with participants in Dallas County, TX between August 2021 and February 2022. All participants were referred from women's health clinics at the county's safety-net hospital system to an on-site drop-off childcare center by hospital staff who identified lack of childcare as a barrier to health care access. Participants were the primary caregiver for at least one child ≤age 13. Interviews were conducted in English or Spanish. We analyzed data using thematic content analysis. Results: We interviewed 22 participants (mean age 34); participants were adult women, had on average 3 children, and primarily identified as Hispanic or African American. Three interrelated themes emerged: disruptions in access, competing priorities, and exacerbated psychological distress. Conclusions: Findings demonstrate how low-income women with young children in a safety-net health system struggle to address their own health needs amid childcare and other household demands. Our study advances our understanding of childcare as a social domain of health, a necessary step to inform how we build structural support systems and drive policy interventions.

5 November 2021 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
BABilal Ashraf
Bilal Ashraf
EHEmily Hoff
Emily Hoff
LBL Steven Brown
L Steven Brown
JSJillian Smartt
Jillian Smartt
SMSheryl Mathew
Sheryl Mathew
KBKavita Bhavan
Kavita Bhavan
Uninsured people who use drugs (PWUD) require extended parenteral antibiotic therapy when diagnosed with complex infections such as osteomyelitis. They are ineligible to enroll in our self-administered outpatient antimicrobial therapy (S-OPAT) program and instead sent to a skilled nursing facility (SNF). We aim to retrospectively assess clinical outcomes of PWUD discharged from our safety net hospital to complete OPAT in an SNF. Using our hospital electronic medical record, PWUD discharged to an SNF for extended antibiotic therapy were identified for the study period, 1/1/17–4/30/18. Demographics, drug use, discharge diagnosis, antibiotic therapy, discharge disposition from SNF (AMA, early non-AMA, completed), 30-day emergency department (ED) utilization, and 30-day readmission were collected for the study cohort. ED utilization and 30-day readmission rates were analyzed by disposition group. While the majority of patients completed treatment (83), a sizeable number left AMA (26) or early non-AMA (20). Patients who left early, AMA or non-AMA, had increased rates of 30-day readmission or ED utilization (P=.01) and increased rates of 30-day readmission alone (P=.01), but not ED utilization alone (P=.43), compared with patients who completed treatment. In our cohort, many PWUD discharged to an SNF to receive parenteral antibiotics did not complete treatment. These patients were observed to have increased health care utilization compared with patients completing therapy.

18 January 2026 in Diabetologia
Verified
Journal Article
Open access
OOOrhan Kemal Oz
Orhan Kemal Oz
ASAmber M. Sherwood
Amber M. Sherwood
PCPeter A. Crisologo
Peter A. Crisologo
AKAmanda L. Killeen
Amanda L. Killeen
KBKavita Bhavan
Kavita Bhavan
LLLawrence A. Lavery
Lawrence A. Lavery
Osteomyelitis is a common complication of diabetic foot ulcers and a leading cause of lower limb amputations globally. Accurate diagnosis of diabetic foot osteomyelitis (DFO) is essential for effective infection management and improving prognosis. This study aimed to compare the performance of white blood cell (WBC)-single photon emission computed tomography (SPECT)/computed tomography (CT) and conventional MRI in the initial diagnosis of DFO and in detecting residual infection during treatment monitoring, using bone biopsy as the reference standard. In this prospective clinical study, 47 patients with foot wounds suspicious for DFO underwent 99mTc-WBC SPECT/CT and MRI, followed by bone biopsy. After receiving a standard course of antibiotics, 20 patients returned for post-treatment imaging and a repeat biopsy. All imaging studies and histopathology were blindly interpreted as positive or negative for DFO. Biopsies were considered positive if either bone cultures or histopathology indicated osteomyelitis. Imaging results were evaluated against biopsy to determine the diagnostic performance of each method before and after treatment. For initial DFO diagnosis, WBC SPECT/CT demonstrated sensitivity, specificity, positive predictive value and negative predictive value of 85%, 79%, 90% and 69%, respectively, while MRI yielded corresponding values of 73%, 43%, 75% and 40%. Following antibiotic therapy, WBC SPECT/CT and MRI shared identical sensitivities, specificities, positive predictive values and negative predictive values of 75%, 75%, 43% and 92%. WBC SPECT/CT exhibits greater sensitivity and specificity than MRI at initial diagnosis. However, after treatment, WBC SPECT/CT and MRI perform equivalently in determining therapeutic response. Our results indicate WBC SPECT/CT is a viable, if not superior, method for primary non-invasive assessment of suspected DFO. To our knowledge, this is the first study to use paired bone biopsy to validate imaging in diabetic foot infections both before and after antibiotic intervention.

9 August 2022 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
AGAnisha Ganguly
Anisha Ganguly
CFCarolina de la Flor
Carolina de la Flor
KAKristin Alvarez
Kristin Alvarez
LBL. Steven Brown
L. Steven Brown
NMNorman S. Mang
Norman S. Mang
KBKavita P. Bhavan
Kavita P. Bhavan
Background: Antistaphylococcal penicillins and cefazolin are the treatments of choice for methicillin-susceptible Staphylococcus aureus (MSSA) infections, requiring multiple doses daily. At Parkland, eligible uninsured patients with MSSA bloodstream infections (BSI) receive self-administered outpatient parenteral antimicrobial therapy (S-OPAT). Ceftriaxone was used in a cohort of S-OPAT patients for ease of once-daily dosing. Objective: A retrospective study was conducted to evaluate clinical outcomes for patients discharged with ceftriaxone versus cefazolin to treat MSSA BSI. Methods: A retrospective cohort noninferiority study design was used to assess treatment efficacy of ceftriaxone versus cefazolin among Parkland S-OPAT patients treated from April 2012 to March 2020. Demographic, clinical, and treatment-related adverse events data were collected. Clinical outcomes included treatment failure as defined by repeat positive blood culture or retreatment within 6 months, all-cause 30-day readmission rates, and central line–associated bloodstream infection (CLABSI) rates. Results: Of 368 S-OPAT patients with MSSA BSI, 286 (77.7%) received cefazolin, and 82 (22.3%) received ceftriaxone. Demographics and comorbidities were similar for both groups. There were no treatment failures in the ceftriaxone group compared with 4 (1%) in the cefazolin group ( P = 0.58). No difference in 30-day readmission rate between groups was found. The CLABSI rates were lower in ceftriaxone group (2%) compared with cefazolin (11%; P = 0.02). Limitations include retrospective cohort design. Conclusions: Ceftriaxone was found to be noninferior to cefazolin in this study. Our findings suggest that ceftriaxone is a safe and effective treatment of MSSA BSI secondary to osteoarticular or skin and soft tissue infections when used in the S-OPAT setting. Poster OFID on 2018 Nov; 5(Suppl 1): S316: doi: 10.1093/ofid/ofy210.894.

1 September 2014 in The Foot
Verified
Journal Article
Closed access
JFJavier La Fontaine
Javier La Fontaine
KBKavita Bhavan
Kavita Bhavan
TTTalal K. Talal
Talal K. Talal
LLLawrence A. Lavery
Lawrence A. Lavery

23 March 2026 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
KJKendall Johnson
Kendall Johnson
KAKristin S. Alvarez
Kristin S. Alvarez
AJAnna Jaybanks
Anna Jaybanks
JSJillian Smartt
Jillian Smartt
MHMichael Harms
Michael Harms
KBKavita P. Bhavan
Kavita P. Bhavan